Betta Pharmaceuticals Co., Ltd. (SHE:300558)
57.42
+0.53 (0.93%)
Nov 3, 2025, 3:04 PM CST
Betta Pharmaceuticals Market Cap
Betta Pharmaceuticals has a market cap or net worth of 23.94 billion as of November 3, 2025. Its market cap has increased by 24.42% in one year.
Market Cap
23.94B
Enterprise Value
25.98B
Revenue
3.26B
Ranking
n/a
PE Ratio
78.96
Stock Price
57.42
Market Cap Chart
Since November 7, 2016, Betta Pharmaceuticals's market cap has increased from 10.15B to 23.94B, an increase of 135.93%. That is a compound annual growth rate of 10.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 23.94B | 6.06% |
| Dec 31, 2024 | 22.57B | 4.62% |
| Dec 29, 2023 | 21.57B | 5.11% |
| Dec 30, 2022 | 20.53B | -38.09% |
| Dec 31, 2021 | 33.15B | -25.26% |
| Dec 31, 2020 | 44.36B | 68.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 426.22B |
| WuXi AppTec | 294.61B |
| Shenzhen Mindray Bio-Medical Electronics | 260.07B |
| Sichuan Biokin Pharmaceutical | 153.99B |
| Shanghai United Imaging Healthcare | 114.74B |
| Aier Eye Hospital Group | 113.87B |
| Zhangzhou Pientzehuang Pharmaceutical., | 107.47B |
| Yunnan Baiyao Group Co.,Ltd | 101.10B |